NeurogesX Inc (OTC Pink - Limited Information:NGSX)
| 0.011 Data as of 12:45pm ET |  +0.001 / +10.00%Today’s Change | 0.01 Today|||52-Week Range 0.41 | -95.32% Year-to-Date |
Latest NGSX News | Press Releases
No recent news for NeurogesX Inc.
Today’s Trading
| Previous close | 0.01 |
| Today’s open | 0.01 |
| Day’s range | 0.01 - 0.02 |
| Volume | 12,390 |
| Average volume (3 months) | 250,593 |
| Market cap | -- |
| Dividend yield | -- |
Data as of 12:45pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +14.34% |
| Earnings growth (this year) | +65.58% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +39.16% |
| P/E ratio | NM |
| Price/Sales | 1.64 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Last reporting date | March 7, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $11.5M |
| Annual profit (last year) | -$49.5M |
| Net profit margin | -430.71% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Ronald A. Martell |
Chief Operating Officer, CFO, Secretary & EVP Stephen F. Ghiglieri, CPA |
Corporate headquarters San Mateo, California |
Forecasts
